Michael Kane

Michael Kane is the Chief Executive Officer of MedPharm, Ltd. Mr. Kane’s career includes over 20 years of experience in leading pharmaceutical and health & wellness businesses across Rx, generic OTC, and infant formula regulatory segments in CEO, COO, and other senior operating roles. This experience spanned topical, soft gel, tablet, powder, and liquid dosage forms. Most recently, he was the COO at the International Vitamin Corporation. Previous to that Mr. Kane was an Operating Partner with Blue Point Capital Partners, and CEO of a topical CDMO focused in Rx, Generic, OTC, and Dx Dispensed products. Prior to his involvement with privately held enterprises, he held a series of progressive leadership roles with Novartis and Abbott Laboratories and has worked with such leading brands as Similac®, Ensure®, Gerber®, Selsun Blue® and Murine®/Clear Eyes®. Mr. Kane currently serves as an Advisor for the University of Notre Dame’s Mendoza School of Business MBA program. Mr. Kane earned his MBA from the University of Notre Dame and a Bachelor of Science in Business Management from Indiana University of Pennsylvania. He also served as a Captain in the United States Marine Corps.